Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

IMV Inc. - Common Shares (NQ: IMV )

N/A UNCHANGED
Last Price Updated: 3:58 PM EDT, Apr 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IMV Inc. - Common Shares

< Previous 1 2 3 4 5 Next >
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,... 
Via Benzinga
Exposures Product Safety
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
Via Benzinga
Exposures Product Safety
IMV Inc. Announces Second Quarter 2021 Financial and Operational Results
From IMV Inc.
Via Business Wire
IMV's Shares Jump As Ovarian Cancer Candidate Shows Overall Survival Rate Of 44.9%
IMV Inc (NASDAQ: IMV) has announced the final topline results of the DeCidE1 Phase 2 trial evaluating maveropepimut-S (MVP-S, formerly known as DPX-Survivac) for... 
Via Benzinga
IMV Announces Final Topline Results of the DeCidE1 Clinical Trial in Advanced Recurrent Ovarian Cancer
From IMV Inc.
Via Business Wire
IMV Announces CEO Transition
From IMV Inc.
Via Business Wire
IMV Inc. to Announce Second Quarter 2021 Results and Host a Conference Call and Webcast on August 11, 2021
From IMV Inc.
Via Business Wire
IMV to Participate in the BTIG Virtual Biotechnology Conference
From IMV Inc.
Via Business Wire
44 Stocks Moving In Tuesday's Mid-Day Session
Gainers Oragenics, Inc. (NASDAQ: OGEN) surged 55.9% to $0.9749 after the company announced it entered into a licensing agreement with the National Research Council of Canada that... 
Via Benzinga
62 Biggest Movers From Yesterday
Gainers Intrusion Inc. (NASDAQ: INTZ) shares surged 52.1% to settle at $5.14 on Tuesday. Intrusion recently issued worse-than-expected preliminary Q2 sales results and announced... 
Via Benzinga
34 Stocks Moving in Tuesday's Pre-Market Session
Gainers Eyegate Pharmaceuticals Inc (NASDAQ: EYEG) shares rose 139.7% to $7.48 in pre-market trading after the company announced it entered a non-binding letter of intent to... 
Via Benzinga
74 Biggest Movers From Yesterday
Gainers Bit Digital, Inc. (NASDAQ: BTBT) shares jumped 109.7% to close at $8.87 on Monday after the company announced it entered into a second strategic co-mining agreement with... 
Via Benzinga
48 Stocks Moving In Monday's Mid-Day Session
Gainers Bit Digital, Inc. (NASDAQ: BTBT) gained 38% to $5.83 after the company announced it entered into a second strategic co-mining agreement with Digihost Technology Inc. The... 
Via Benzinga
40 Stocks Moving in Monday's Pre-Market Session
Gainers Dynatronics Corporation (NASDAQ: DYNT) shares rose 73.6% to $2.24 in pre-market trading after gaining over 9% on Friday. NanoVibronix Inc (NASDAQ: NAOV) shares rose 45.2... 
Via Benzinga
IMV Inc. Closes Previously Announced Public Offering
From IMV Inc.
Via Business Wire
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated... 
Via Benzinga
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15) IVERIC bio, Inc. (NASDAQ:... 
Via Benzinga
Topics Stocks
Exposures US Equities
54 Biggest Movers From Yesterday
Gainers Sight Sciences, Inc. (NASDAQ: SGHT) shares jumped 39.6% to settle at $33.50 on Thursday as the company priced its IPO at $24 per share. Cinedigm Corp. (NASDAQ: CIDM)... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Mid-Afternoon Market Update: Nasdaq Drops 100 Points; FVCBankcorp Shares Jump
Toward the end of trading Thursday, the Dow traded up 0.11% to 34,973.31 while the NASDAQ fell 0.69% to 14,543.67. The S&P also fell, dropping 0.29% to 4,361.49. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
Mid-Day Market Update: Crude Oil Down Over 1%; Cinedigm Shares Spike Higher
Midway through trading Thursday, the Dow traded down 0.04% to 34,918.42 while the NASDAQ fell 0.52% to 14,568.88. The S&P also fell, dropping 0.30% to 4,361.05. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
32 Stocks Moving In Thursday's Mid-Day Session
Gainers ATA Creativity Global (NASDAQ: AACG) shares jumped 37.8% to $4.1050. Verb Technology Company, Inc. (NASDAQ: VERB) shares jumped 20.9% to $3.01. Verb Technology shares... 
Via Benzinga
Mid-Morning Market Update: Markets Mostly Lower; Morgan Stanley Tops Q2 Views
Following the market opening Thursday, the Dow traded down 0.22% to 34,856.63 while the NASDAQ rose 0.01% to 14,645.82. The S&P also fell, dropping 0.17% to 4,366.76. The U.S... 
Via Benzinga
Topics Stocks
Exposures US Equities
IMV Stock Plunges After Raising $25M Via Equity Issued At 16% Discount
IMV Inc (NASDAQ: IMV) has priced its previously-announced underwritten public offering of 14.3 million shares at $1.75 per Unit, for gross proceeds of... 
Via Benzinga
IMV Inc. Announces Pricing of Public Offering
From IMV Inc.
Via Business Wire
IMV Inc. Files Preliminary Prospectus Supplement for Proposed Public Offering of Units
From IMV Inc.
Via Business Wire
The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alexion Pharmaceuticals,... 
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) Ambrx Biopharma Inc. (NYSE:... 
Via Benzinga
Topics Product Recall
Exposures COVID-19 Legal Product Safety
The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 6) Ambrx Biopharma Inc. (NYSE:... 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Before 10 a.m. ET on Friday, 43 companies set new 52-week lows. Points of Interest: Autohome (NYSE:ATHM) was the largest firm by market cap to set a new 52-week low... 
Via Benzinga
The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 30) Ambrx Biopharma Inc. (NYSE... 
Via Benzinga
Exposures Product Safety
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.